Julie Riley, MS, RD
Urinary incontinence is the loss of voluntary bladder control that can cause leakage of urine. It can be temporary or last for a long time.
There are four types of long term or permanent incontinence:
People may have just one or a combination of these types.
Incontinence has several different causes. The cause could also be unclear.
Temporary incontinence can be caused by:
Some incontinence may be caused by a fistula. A fistula is an abnormal opening between the bladder and another nearby structure. The fistula can make it difficult for the bladder to act as it should.
Urinary incontinence is more common in women age 65 years or older.
Factors that may increase the risk of urinary incontinence include:
Any loss of bladder control can be considered incontinence.
Call your doctor if you have a loss of urine control. Your doctor can help you determine the underlying cause.
Your doctor will ask about your symptoms and medical history. You will be asked how often you empty your bladder and patterns of urine leakage. Your doctor will do a physical exam to look for any physical causes such as blockages or nerve problems. You may be referred to a specialist.
Your bodily fluids will be tested. This can be done with:
The flow of your urine will be assessed. This can be done with:
Your bodily structures may need to be viewed. This can be done with:
Treatments are based on the cause of the urinary incontinence.
Temporary incontinence may be relieved by managing the conditions associated with the incontinence.
Weight loss may help reduce the number of episodes due to stress or urge incontinence in people who are overweight or obese. Talk to your doctor about a
weight loss program
that is right for you.
Initial treatment relies on behavior changes and strengthening pelvic floor muscles. Behavior changes include:
Methods to increase strength in the pelvic floor muscles include:
Surgical procedures may be done for incontinence that is not responding to these treatments. Surgical options include:
Initial treatment depends on behavior changes and strengthening pelvic floor muscles. Behavior changes include:
Kegel exercises can help strengthen pelvic floor muscles and relieve some symptoms.
Medications may be recommended. Anticholinergics is the most common medication. They can relax the muscles of the bladder. Other medications may be used in combination to help manage symptoms.
Nerve stimulation may be used if urge incontinence does not respond to behavior modification or medication. A device will send pulses to the nerves that control the bladder. This has been shown to help stimulate bladder control. In some cases, the device is implanted in the back.
Treatment for overflow incontinence is to allow the bladder to completely empty. If a blockage is causing the problems, surgery may be needed to open the urine pathways.
Other causes of overflow incontinence may require the use of a tube called a catheter to allow urine to drain from the bladder. People can use certain catheters at home.
Absorbent pads or diapers can be used to manage urinary leakage. Plugs and patches can also be used to help hold urine in place.
A supportive device called a pessary may also be used.
Pessaries are devices that raise the uterus or the prolapsed bladder. It can decrease pressure on the bladder.
Incontinence is a symptom of many other conditions. There are several ways to prevent incontinence:
Urology Care Foundation
National Institute of Diabetes and Digestive and Kidney Diseases
Women's Health Matters
Corcos J, Gajewski J, et al. Canadian Urological Association guidelines on urinary incontinence.
Can J Urol. 2006;13:3127-3138.
Incontinence. American Urologic Association Foundation website. Available at:
http://www.urologyhealth.org/urology/index.cfm?article=143. Updated March 2013. Accessed December 2, 2013.
Overactive bladder. American Urological Association Foundation website. Available at:
http://www.urologyhealth.org/urology/index.cfm?article=112. Updated March 2013. Accessed December 2, 2013.
Norton P, Brubaker L. Urinary incontinence in women.
Sobhgol SS, Charandabee SM. Related factors of urge, stress, mixed urinary incontinence, and overactive bladder in reproductive age women in Tabriz, Iran: a cross-sectional study.
Int Urogynecol J Pelvic Floor Dys Function.
Urinary incontinence. American Academy of Family Physicians. Available at:
http://familydoctor.org/familydoctor/en/diseases-conditions/urinary-incontinence.html. Updated July 2010. Accessed December 2, 2013.
Urinary incontinence in women. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed. Updated October 31, 2013. Accessed December 2, 2013.
Urinary incontinence in women.
National Institute of Diabetes and Digestive and Kidney Diseases website. Available at:
http://kidney.niddk.nih.gov/kudiseases/pubs/uiwomen. Updated September 18, 2013. Accessed December 2, 2013.
Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis, and management.
J Urol. 2006;175:S5-10.
What is incontinence? National Association for Continence website. Available at:
http://www.nafc.org/bladder-bowel-health. Accessed December 2, 2013.
2/5/2009 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us: Subak L, Wing R, Smith West D, et al. Weight loss to treat urinary incontinence in overweight and obese women.
N Engl J Med.
1/11/2010 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: AHRQ evidence report on treatment for overactive bladder in women 2009. Agency for Healthcare Research and Quality website. Available at:
http://www.ahrq.gov. Published August 2009. Accessed January 11, 2010.
3/5/2010 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Vardy MD, Mitcheson HD, Samuels TA, et al. Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT—a double-blind, placebo-controlled trial.
Int J Clin Pract.
12/3/2010 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Cardozo L, Khullar V, Wang JT, Guan Z, Sand PK.
Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?
12/13/2010 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: University of Texas at Austin, School of Nursing, Family Nurse Practitioner Program. Recommendations for the management of urge urinary incontinence in women. Agency for Healthcare Research and Quality website. Available at:
http://www.guideline.gov/content.aspx?id=16322. Published May 2010. Accessed December 13, 2010.
3/5/2013 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Boyle R, Hay-Smith EJ, Cody JD, et al. Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev. 2012 Oct 17;10:CD007471.
Last reviewed December 2013 by Adrienne Carmack, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.